These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24581497)

  • 1. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.
    Pencheva N; Buss CG; Posada J; Merghoub T; Tavazoie SF
    Cell; 2014 Feb; 156(5):986-1001. PubMed ID: 24581497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LXR agonism inhibits metastatic melanoma through activation of ApoE.
    Cancer Discov; 2014 May; 4(5):OF16. PubMed ID: 24795020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate.
    Lim RK; Yu S; Cheng B; Li S; Kim NJ; Cao Y; Chi V; Kim JY; Chatterjee AK; Schultz PG; Tremblay MS; Kazane SA
    Bioconjug Chem; 2015 Nov; 26(11):2216-22. PubMed ID: 25945727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.
    Pencheva N; Tran H; Buss C; Huh D; Drobnjak M; Busam K; Tavazoie SF
    Cell; 2012 Nov; 151(5):1068-82. PubMed ID: 23142051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
    Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melanoma metastasis X-factor.
    Haq R; Flaherty K
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):698. PubMed ID: 24953382
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticancer drugs: A new weapon against metastatic melanoma.
    Kingwell K
    Nat Rev Drug Discov; 2014 May; 13(5):334. PubMed ID: 24781544
    [No Abstract]   [Full Text] [Related]  

  • 10. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation.
    Lee CS; Park M; Han J; Lee JH; Bae IH; Choi H; Son ED; Park YH; Lim KM
    J Invest Dermatol; 2013 Apr; 133(4):1063-71. PubMed ID: 23223141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
    Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM
    J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
    Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
    J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.
    He Q; Pu J; Yuan A; Lau WB; Gao E; Koch WJ; Ma XL; He B
    Circ Heart Fail; 2014 Nov; 7(6):1032-41. PubMed ID: 25277999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.